HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here - Baidu (NASDAQ:BIDU), Bristol-Myers Squibb (NYSE:BMY)

Susquehanna cut the price target on Baidu, Inc. (NASDAQ:BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in pre-market trading.
Morgan Stanley lowered the price target for Celularity Inc. (NASDAQ:CELU) from $8 to $5. Morgan Stanley analyst Jeffrey Hung maintained the stock with an Equal-Weight. Celularity shares rose 1.6% to $2.50 on Friday.
BMO Capital raised the price target on Bristol-Myers Squibb Company (NYSE:BMY) from $92 to $94. Bristol-Myers Squibb shares rose 6.9% to $75.01 in pre-market trading.
Piper Sandler boosted the price target for Comerica Incorporated (NYSE:CMA) from $90 to $94. Comerica shares rose 0.1% to $84.57 in pre-market trading.
Wells Fargo cut the price target on Charter Communications, Inc. (NASDAQ:CHTR) from $393 to $370. Charter Communications shares rose 0.1% to $406.05 in pre-market trading.
Barclays cut the price target for Thermo Fisher Scientific Inc. (NYSE:TMO) from $685 to $595. Thermo Fisher Scientific shares rose 0.8% to $573.99 in pre-market trading.
HC Wainwright & Co. lowered the price target on Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) from $22 to $6. Neoleukin Therapeutics shares jumped 5.8% to close at $1.09 on Friday.

Don’t forget to check out our premarket coverage here .

To add Benzinga News as your preferred source on Google, click here.